Sparks commentary - IP Group

TMT

Sparks - IP Group

More on this equity
IP Group (LSE:IPO) – Istesso published encouraging data
Published by Milosz Papst

IP Group announced that its portfolio company Istesso published encouraging data in the peer reviewed monthly, The Journal of Pharmacology and Experimental Therapeutics, demonstrating its new class of orally administered investigational medicines elicit tissue repair in fibrotic, autoinflammatory and autoimmune conditions. The published data is preclinical and therefore still early stage, but we consider it good news as it provides the initial support to the company’s plans for additional clinical studies for Leramistat, focused on tissue repair and fibrosis. See our February 2025 update note for further background.

Latest

TMT | Comment

Cordel – Positive progress with PTC

Healthcare | Comment

Cantargia (OMX: CANTA): CAN10 programme acquired by Otsuka

Energy & Resources | Comment

bp (BP:LSE) – Updated Q225 guidance

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free